Clinical Trial Update: A Long Term Study of GK530G in Subjects With Acne Vulgaris [Phase 3]

View source ↗

Summary

A long-term Phase 3 study of GK530G in acne vulgaris has completed and results were posted in January 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acne Vulgaris

Drugs mentioned

• GK530G

Snippet

Sponsor: Galderma R&D | Conditions: Acne Vulgaris | Phase 3 | Status: COMPLETED | Results posted: 2017-01-05